期刊文献+

2型糖尿病患者血小板凝血酶敏感蛋白的临床意义 被引量:2

下载PDF
导出
摘要 目的探讨血小板凝血酶敏感蛋白与糖尿病血管并发症的关系。方法用流式细胞术测定102例2型糖尿病患者血液中血小板凝血酶敏感蛋白(thrombospondir,TSP)的含量,并与60例健康对照组相比较。结果2型糖尿病患者血液中TSP含量明显高于健康对照组(P<0.01),糖尿病有血管病变组血液中TSP含量又明显高于糖尿病无血管病变组(P<0.01)。结论血小板凝血酶敏感蛋白与血管病变的发生与发展有关,是反映2型糖尿病血管病变的高度危险因素之一。
出处 《四川医学》 CAS 2008年第10期1357-1358,共2页 Sichuan Medical Journal
  • 相关文献

参考文献8

二级参考文献24

  • 1[1]Printseva OY, Pedo MM, Goun AM, et al. Variable cell types in human atherosderoeiclestons express IEAM-1 J[J], Am J Pathol,1992, 140 (5):889-896.
  • 2[2]Prescigiacomo MD,Kim SC,Connolly-ES Jr, et al. CD18-medialed neutrophil recruitment contributes to the pathogenesis of reperfused but not non-reperfused stroke [J].Stroke, 1999, 30(5):1 110-1 117.
  • 3[1]Fitzgerald DJ, Louis R. Platelet activation in unstable coronary disease[J]. N Engl J Med,1986,315:983
  • 4[2]Singh N, Gemell CH, Paly PA, et al. Elevated platelet-derived microparticle levels during unstable angina [J]. Can J Cardiol,1995,11 (11) :1015
  • 5[3]Murakamin T. Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease[J]. Eur J Clin Invest, 1996,26 ( 11 ): 996
  • 6[4]Itoh T, Nakai K,Ono M,et al. Can the risk for acute cardiac events in acute coronary syndrome be indicated by platelet membrane activation marker P-selectin [J] ? Coron Artery Dis, 1995,6(8) :645
  • 7[5]Mickelson JK, Hoff PT. High dose intravenous aspirin, not low dose intravenous or oral aspirin, inhibits thrombus formation and stabilizes blood flow in experimental coronary vascular injury[J ]. J Am Coil Cardiol, 1993,21 (2): 502
  • 8徐燕丽,放射免疫学杂志,1994年,7期,258页
  • 9Wu G X,Haemostasis,1993年,23卷,121页
  • 10吴国新,中华核医学杂志,1993年,13卷,232页

共引文献82

同被引文献16

  • 1陈玲,胡建新.血小板反应蛋白-1与缺血性心血管疾病[J].世界临床药物,2007,28(1):52-55. 被引量:2
  • 2Y. Takeda,Y. Fujita,J. Honjo,T. Yanagimachi,H. Sakagami,Y. Takiyama,Y. Makino,A. Abiko,T. J. Kieffer,M. Haneda.Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice[J].Diabetologia.2012(2)
  • 3Toklu HZ,DumLu MU,Sehirli O,et al.Pomegranatepeel extract prevents liver fibrosis in biliary-obstructedrats[].Journal of Pharmacokinetics and Pharmacodynamics.2007
  • 4Pande, G,Akoh C.C.Antioxidant Capacity and Lipid Characterization of Six Georgia-Grown Pomegranate Cultivars[].Journal of Agriculture.2009
  • 5Parmar HS,Kar A.Antidiabetic potential of Citrus sinensis and Punica granatum peel extracts in alloxan treated male mice[].Biol Factors.2007
  • 6Nigris F,Balestrieri M L,Williams Ignarro S, et al.The influence pomegranate fruit extract in comparison to regular pomegranate and seed oil on nitric oxide and arterial function in obese Zucker rate[].Nitric Oxide.2007
  • 7Neyrinck AM,Van Hée VF,Bindels LB,et al.Polyphenol-rich extractof pomegranate peel alleviates tissue inflammation and hypercholesterolaemiain high-fat diet-induced obese mice:potential implication of the gut microbio-ta[].British Journal of Nutrition.2012
  • 8Parmar HS,Kar A.Medicinal values of fruit peels from Citrus sinensis,Punica granatum,and Musa paradisiaca with respect to alterations in tissuelipid peroxidation and serum concentration of glucose,insulin,and thyroidhormones[].Journal of Medicinal Food.2008
  • 9Mark Evans.The UK Prospective Diabetes study[].The Lancet.1998
  • 10热娜.卡斯木,帕丽达.阿不力孜,张笑颖.新疆石榴皮化学成分研究[J].中药材,2009,32(3):363-365. 被引量:22

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部